Cargando…
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation
Ipilimumab is a first-in-class immunological checkpoint blockade agent and monoclonal antibody against Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) that has demonstrated survival benefit and durable responses in patients with metastatic melanoma. To date, solid organ transplant recipients have been exc...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469313/ https://www.ncbi.nlm.nih.gov/pubmed/26082835 http://dx.doi.org/10.1186/s40425-015-0066-0 |